Barcelona
 
Home
Welcome Note
Faculty List
Committees
Timetable
Scientific Program
Satellite Symposia
Thursday
Friday
Saturday
Sunday
Abstracts
Abstract Submission
Best Abstract Awards
Sponsorship & Exhibition
Sponsors
Exhibitors
CME
Registration
Invitation Letter
Accommodation
Poster Presentation
Poster List
Abstracts List
Poster Presentation Guidelines
General Information
Before you Travel
Things to Do
Italian Agent
Previous and upcoming CODHy Congresses
Partners
Links
Contact Us

  Poster List Print
Board #
BARIATRIC SURGERY
1
A CASE OF A LATE ANASTOMOTIC LEAK POST GASTRIC BYPASS FOR OBESITY
D.S.Z.M. Boctor
, I.G.I. Suliman, S. Low
2
IMPACT OF BARIATRIC SURGERY ON PREGNANCY COMPLICATIONS- ABOUT 2 CASE CONTROL STUDIES
S.H. Haddad , E.B. Boudier, M.V. Vix, P.K. Keller , I.N. Nisand
3
REMISSION OF DIABETES AND HYPERTENSION ACCOMPANYING RAPID WEIGHT REDUCTION FOLLOWING BARIATRIC SURGERY
A.K. Mandal , L.M. Hiebert
4
GLUCOSE AND GLP-1 LEVELS AFTER TEST MEAL BEFORE AND AFTER GASTRIC BYPASS SURGERY IN MORBID OBESE SUBJECTS
D. Micic
, D. Bajec, S. Polovina, D. Radenkovic, M. Sumarac-Dumanovic, P. Gregoric, G. Cvijovic, S. Ignjatovic, M. Dajak, D. Micic, D. Jeremic
5
METABOLIC IMPROVEMENTS SIX MONTHS AFTER BARIATRIC SURGERY
S.P. Polovina
, D. Bajec, M. Sumarac Dumanovic, D. Radenkovic, D. Stamenkovic Pejkovic, G. Cvijovic, D. Micic, J. Glikogorijevic, D. Jeremic, D. Micic
 
 
 
 
Board #
CARDIOVASCULAR DISEASE
6
ALTERATION OF MYOCARDIAL OXIDATIVE STRESS PATTERNED BY OBESITY IN CABG PATIENTS
K. Denk
, Y. Gramlich, M. Oelze, U. Hink, A. Daiber, T. Münzel, C.F. Vahl
7
EFFECTS OF DPP-4 INHIBITORS IN SALIVARY GLANDS OF SPONTANEOUSLY DIABETIC MICE
M.A. Dias
, A.L.D. da Silva Faria, V.B. Leme, E.E. Mayoral, R. Netto, R.E. da Silva, R.D. Mâncio, E.J. Caldeira
8
THE VASCULAR STIFFNESS IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS
O. Georgescu, C. Nica, C.V. Ion, S.V. Fica
9
CORRELATION BETWEEN TISSUE DOPPLER IMAGING AND PLASMA LEVEL OF NT PRO BNP IN ASSESSMENT OF LEFT VENTRICULAR DIASTOLIC FUNCTION IN ASYMPTOMATIC HYPERTENSIVE PATIENTS
M.A. Ghaleb
, W.A. El Aroussy, M.A. Shalaby, H.A. Negm, S.A. Omar
10
WAIST-TO-HIP RATIO AND BODY MASS INDEX AS PREDICTORS OF CARDIOVASCULAR DISEASE
A. Lejnieks
, I. Skuja, G. Krievina, I. Stukena, A. Jurka, P. Tretjakovs
11
INSULIN SENSITIVITY AND ANTIOXIDANT ENZYMES IN DIABETICS AND NONDIABETICS: TRANSIENT ISCHEMIC ATTACK VS STROKE
T.J. Milicic , N. Lalic, A. Jotic, V. Kostic, N. Covickovic-Sternic, K. Lalic, M. Mijailovic, L. Lukic, N. Rajkovic, J. Seferovic-Mitrovic, M. Macesic, J. Stanarcic
12
PREDICTION OF EXTRACRANIAL VASCULAR EVENTS IN PATIENTS WITH TRANSIENT ISCHEMIC ATTACK
N. Miró
, M.B. Vilanova, J. Montserrat-Capdevila, F. Purroy, M. Falguera, M. Roca, A. Balcells, D. Rios, A. Quesada, M. Caldero, V. Sanchez, M. Pena
13
PREDICTORS OF HOSPITALIZATION IN PATIENTS WITH EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
J. Montserrat-Capdevila , P. Godoy, J.R. Marsal, I. Cruz, M.G. Mo-Gasol, M.B. Vilanova, M. Caldero, R. Llovet, M. Álvarez, X. Ferrer, V. Sánchez, M. Pena
14
PREVALENCE OF PERIPHERAL ARTERY DISEASE AND METABOLIC SYNDROME IN PATIENTS WITH TRANSIENT ISCHEMIC ATTACK
J. Montserrat-Capdevila , M.B. Vilanova, M. Caldero, R. Llovet, V. Sanchez, M. Pena, M.G. Mo-Gasol, M. Abellana, L. Olivart, E. Miguel, E. Sancho, F. Purroy
15
PREVALENCES OF HYPERLIPIDEMIAS AND ASSOCIATIONS WITH OBESITY IN RURAL CHINESE HYPERTENSIVE: YUHUAN RURAL HEALTH POPULATION COHORT STUDY
M.F. Su , C.W. Fu, S.T. Li, X.B. Ye, N. He, Q.W. Jiang
16
PREVALENCE AND RISK FACTORS OF HIGH-NORMAL BLOOD PRESSURE OF CHONGWEN DISTRICT IN BEIJING
X.Y. Sun , S.Q. Cui, X.Q. Lu, Z.H. Sun, A.M. Guo
 
 
 
 
Board #
CARDIOVASCULAR RISK FACTORS
17
LIPID AND LIPOPROTEIN PROFILES AFTER 14 WEEKS OF ELECTRICAL STIMULATION IN RECENT SPINAL CORD INJURED MEN
A. Arija-Blázquez
, S. Ceruelo-Abajo, J.A. Godino-Durán, F. Navarro-Valdivielso, J. Florensa-Vila
18
THE ROLE OF HEALTH PRODUCTION AS A DETERMINANT OF METS IN A COHORT OF CHILEAN ADOLESCENTS
P. Correa Burrows , M. Reyes, D. Chavez-Yenter, E. Blanco, S. Gahagan, R.A. Burrows
19
MICROPARTICLES IN HYPERTENSIVE AND DIABETIC PATIENTS: EFFECTS OF HYPOLIPIDEMIC THERAPIES COMBINED OR NOT WITH CLOPIDOGREL
C.N. França
, M.C.O. Izar, L.F.M. Pinheiro, J.B. do Amaral, L.L. do Amaral, S.P.M. Barbosa, F.A.H. Fonseca
20
NUTRITIONAL STATUS AND CARDIOVASCULAR RISK FACTORS AMONG KHISÊDJÊ BRAZILIANS INDIGENOUS: A CROSS-SECTIONAL STUDY
S.G.A. Gimeno
, L. Massuccheti, P.O. Paiva, K.M. Santos, D.A. Rodrigues, M.L.S. Tsutsui, L. Mondini
21
ANTI-HYPERTENSIVE TREATMENT INCREASES CAPILLARY DENSITY IN PATIENTS WITH STAGE I AND II HYPERTENSION
S.E. Kaiser , A.F. Sanjuliani, M.B Gomes, E.V. Tibiriçá
22
MULTIMORBIDITY IN THE PATIENTS WITH DIABETES MELLITUS AND ARTERIAL HYPERTENSION AS BASIS FOR DIFFICULTIES IN DIAGNOSTICS AND TREATMENT
S.K. Kulishov , O.M. Iakovenko, N.P. Prikhodko, N.G. Tretiak, M. Sulaiman
23
HYPERTENSION IN OVERWEIGHT TYPE 2 DIABETICS: ASSOCIATION OF INCREASED LEPTIN LEVELS AND INSULIN RESISTANCE
L.Z. Lukic , N.M. Lalic, A. Jotic, N. Rajkovic, N. Milicic, M. Zamaklar, K. Lalic, J.P. Seferovic Mitrovic, M. Macesic, J. Stanarcic
24
TREATMENT STRATEGY FOR HYPERTENSIVE PATIENTS WITH LOW, MEDIAN AND HIGH CARDIOVASCULAR RISK NOT CONTROLLED WITH VALSARTAN/HYDROCHLOROTHIAZIDE
W. Oigman, A. Abuab, F.T. Neves
25
CARDIOVASCULAR RISK MANAGEMENT AND LIPID CONTROL IN DIABETIC AND NON DIABETIC PATIENTS IN A PRIMARY CARE SETTING
M. Pape , A. Smagadi, I. Haritonidis
26
ASSOCIATION BETWEEN JOB STRAIN AND CARDIOVASCULAR RISK IN WORKERS OF A PUBLIC UNIVERSITY
A.M. Pimenta , G. Kac, S.M.F. Silqueira
27
CARDIOVASCULAR RISK FACTORS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS CONTROLLED PRIMARY HEALTH CARE
L. Sierra-Martínez , R. Martínez-Fuerte
 
 
 
 
Board #
CELL LINE/ANIMAL MODEL
28
PEPTIDES P217 AND P290 IMPROVES THE SALIVARY GLANDS OF DIABETIC MICE
E.J. Caldeira , R.D. Mâncio, M.A. Dias, R.E. da Silva, F. Rojas, L. Peroni, P.K. Picardi, R.S.F. Júnior
29
TREATING INSULIN RESISTANCE: CB1 RECEPTOR AS A POTENTIAL TARGET
D.T. Furuya , A.C. Poletto, H.S. Freitas, U.F. Machado
30
EXPERIMENTAL MODEL OF DIABETES MELLITUS TYPE 2 AS A TOOL IN MONITORING CHRONIC STUDIES
A.M. Guadron-Llanos
, I. Leal-Anguiano, S.G. Huerta-Olvera, A.O. Vázquez-Alvarez, A.M Salazar-Montes, A. Miranda-Díaz, E.G. Cardona-Muñoz, A.R. Rincón-Sánchez, M.C. Islas-Carbajal
31
GLYCOGEN SYNTHASE KINASE 3ß (GSK3ß) POSITIVELY REGULATES TLR3-MEDIATED CYTOKINES PRODUCTION
R. Ko
, J.H. Park, S.Y. Lee
32
MOLECULAR SPECIES OF DIACYLGLYCEROL AND TRIGLYCERIDE, AND LIPOLYSIS IN ADIPOSE TISSUE OF OBESITY/DIABETES MODEL MICE
Y. Kobayashi
, M. Fukata, M. Tamura, N. Tagawa
33
EFFECTS OF ANTI-CD3 MONOCLONAL ANTIBODY IN EXTRACELLULAR MATRIX OF SALIVARY GLANDS OF DIABETIC MICE
R.D. Mância , E.E. Mayoral, G.M. Domingues, A.T. Ferri, F.A. Rojas, L.A. Peroni, E.A. Lourenço, E.J. Caldeira
34
THE ROLE OF OBESITY AND AGING IN CARDIOVASCULAR REMODELING IN MONOSODIUM GLUTAMATE TREATED RATS
M.F. Neves , A.K. Burlá, W. Oigman, Z.B. Fortes
35
ANTI-OSTEOPOROTIC ACTIVITY OF PIG PLACENTA HYDROLYSATES IN OVARIECTOMIZED RATS
S. Park , B.S. Ko, J.A. Ryuk
36
EFFECT OF CENTRAL AMPK ACTIVATION ON INSULIN SECRETION AND INSULIN RESISTANCE IN TYPE 2 DIABETES RATS
S. Park
, J.A. Ryuk, B.S. Ko
37
EFFECTS OF A NOVEL BRADYKININ B1 RECEPTOR ANTAGONIST AND ANGIOTENSIN II RECEPTOR BLOCKADE ON AN EXPERIMENTAL MODEL OF MYOCARDIAL INFARCTION IN RATS
D. Wu
, X. Lin, C. Bernloehr, T. Hildebrandt, H. Doods
 
 
 
 
Board #
Diabetes Complications
38
EARLY MARKERS OF ATHEROGENESIS AND RENAL DYSFUNCTION ARE IDENTIFIED IN EARLY STAGES OF ABNORMAL GLUCOSE METABOLISM
B. Almeida-Pititto , F.F. Ribeiro-Filho, P.A. Lotufo, I. Bensenor, S.R.G. Ferreira
39
DIABETES CLINIC PERFORMANCE OVER A PERIOD OF FOUR YEARS AT CONQUEST HOSPITAL, HASTINGS, UK
U.K. Dashora, A. Al-Abdullah
40
LIPID COMPOSITION OF PLATELET MEMBRANES IN PATIENTS WITH RENOCARDIAL SYNDROME
N.V. Demikhova
41
SIGNS OF AN ELEVATED MYOCARDIAL OXIDATIVE STRESS IN DIABETIC CABG PATIENTS
K. Denk
, Y. Gramlich, M. Oelze, U. Hink, A. Daiber, T. Münzel , C.F. Vahl
42
NEEDLE ASPIRATION FOR HEALTHY SKIN PUNCTURE (HSP) OUTPATIENT IN DIABETIC FOOT INFECTED
M.C. Domina , N.S. Segura, R. Rafael, L.M. Carrio, C.L. Vasl
43
THE PREVALENCE OF LATENT TUBERCULOSIS IN PATIENTS WITH DIABETES MELLITUS IN A LOCAL TERTIARY HOSPITAL: COMPARISON OF THE T-SPOT TB TEST WITH THE TUBERCULIN SKIN TEST
M.K.S. Loew , R. Dalan, C.B.E. Chee, A. Earnest, D.E.K. Chew, A. Tan, W.Y.C. Kon, M. Jong, S.Y.T. Wang
44
ASSESSMENT OF CYSTATIN C FOR DETERMINING RENAL FUNCTION IN TYPE 2 DIABETIC PATIENTS
S.M. Pejicic , I. Risovic, V. Vlatkovic, S. Avram, R. Beric, B. Vukovic
45
COMPLICATIONS IN PATIENTS WITH TYPE 2 DIABETES IN PRIMARY CARE OF CASTILLA Y LEON SPAIN
L. Sierra-Martínez , R. Martínez-Fuerte
46
FREQUENCY OF SELECTED NEOPLASIA TYPES AMONG PATIENTS WITH AND WITHOUT DIABETES-RETROSPECTIVE ANALYSIS FROM ONCOLOGY DEPARTMENT-PROVINCE HOSPITAL IN ZIELONA GÓRA , POLAND
E.W.R. Wolny-Rokicka
, E. Sutkowska, B. Iwanowska-Chomiak, P. Myśliwiec, M. Wachowiak, E. Skrzypczak, L. Dębicki, K. Czarny, J. Żurawska, A. Kamińska, K. Sutkowski, J. Lipiński
47
PRE-EXISTING DIABETES MELLITUS IS INCREASING THE RISK OF GASTRIC CANCER: A META-ANALYSIS
J.M. Yoon
, K.Y. Son, C.S. Eom, D. Durrance, S.M. Park
48
INCIDENCE OF SOME VIRAL INFECTIONS AMONG DIABETIC PEOPLES IN NAJAF, IRAQ
M. Yousif
, A.M.S. Baqer, N.A. Abdulkhedir, H.M. Al-alaq
 
 
 
 
Board #
DIABETES SCREENING/MANAGEMENT
49
SELF-MANAGEMENT COMPARISON OF ADULTS WITH TYPE 1 DIABETES IN LATIN AMERICA AND THE MIDDLE EAST: DATA FROM THE IDMPS
J.J. Gagliardino, P. Aschner, J. Chan, J.M. Chantelot, E. Genestin, M.P. Dain, H. Ilkova, F.J. Lavelle-González, A. Ramachandran
50
PATIENTS’ AND HEALTHCARE PROFESSIONALS’ PERSPECTIVE OF TYPE 2 DIABETES MELLITUS MANAGEMENT: A FOCUS-GROUP STUDY
P. Kardas , M. Mazurkiewicz, D. Kurpas
51
ASSOCIATION OF HEALTH BEHAVIORS, USE OF PREVENTIVE SCREENING SERVICES, AND INSIGHT AND TREATMENT OF CHRONIC DISEASES: CROSS-SECTIONAL STUDY USING KNHANES IV
Y. Kwon , B. Cho
52
ASSESSMENT OF CYSTATIN C FOR DETERMINING RENAL FUNCTION IN TYPE 2 DIABETIC PATIENTS
S.M. Pejicic , I. Risovic, V. Vlatkovic, S. Avram, R. Beric, B. Vukovic
53
EDUCATION OF ADULTS WITH TYPE 1 DIABETES IN LATIN AMERICA AND THE MIDDLE EAST: RESULTS FROM THE IDMPS
A. Ramachandran
, P. Aschner, J. Chan, J.M. Chantelot, E. Genestin, M.P. Dain, H. Ilkova, F.J. Lavelle-González, J.J Gagliardino
54
USEFULNESS OF HBA1C IN SCREENING FOR DIABETES MELLITUS: EVIDENCE FROM AN URBAN SRI LANKAN COMMUNITY
C.N. Wijekoon
, A. Pathmeswaran, S. Chackrewarthy, N. Kato, A.R. Wickremasinghe
55
UTILITY OF HBA1C IN DETECTING IMPAIRED FASTING GLYCAEMIA: EVIDENCE FROM AN URBAN SRI LANKAN COMMUNITY
C.N. Wijekoon
, A. Pathmeswaran, S. Chackrewarthy, N. Kato, A.R. Wickremasinghe
 
 
 
 
Board #
DIABETES TREATMENT: INCRETIN & MORE
56
LIRAGLUTIDE+METFORMIN IN T2D: CLINICAL BENEFITS WITH EARLY USE OF LIRAGLUTIDE AND SWITCH FROM SU
S.C. Bain
, J. Seufert, A.B. Thomsen, T.M. Jensen, D. D'Alessio
57
PATIENTS MORE OFTEN REACH A1C TARGET WHEN LIRAGLUTIDE IS ADDED TO AN SU VS. ADDING ROSIGLITAZONE OR PLACEBO
M. Brandle
, S. Colagiuri, C.B. Svendsen, T.M. Jensen, M. Marre
58
LIRAGLUTIDE IN PEDIATRIC T2D: SAFETY, TOLERABILITY AND PHARMACOKINETICS/PHARMACODYNAMICS
D.J. Klein
, T. Battelino, T.M. Jensen, P.M. Hale, S. Arslanian
59
LIRAGLUTIDE IN PAEDIATRIC SUBJECTS WITH T2D: A POPULATION PK ANALYSIS AND COMPARISON WITH ADULTS
K.C.C. Petri
, L.V. Jacobsen, T.M. Jensen, D.J. Klein
60
GLP-1, GIP AND GLUCAGON LEVELS DYNAMICS IN HIGH RISK NON-DIABETIC SUBJECTS FOLLOWING OGTT
E.A. Shestakova, A.V. Ilyin, M.V. Shestakova, I.I. Dedov
61
TWO YEARS ASSESSMENT OF VILDAGLIPTIN SAFETY AND EFFICACY IN TYPE 2 DIABETES PATIENTS (T2DM) IN RUSSIAN REAL CLINICAL SETTING
A.V. Zilov , M.V. Shestakova
 
 
 
 
Board #
DIABETES TREATMENT: SGLT2
62
LONG-TERM EFFICACY OF DAPAGLIFLOZIN AS ADD-ON TO METFORMIN (MET) IN T2DM INADEQUATELY CONTROLLED WITH MET ALONE
C.J. Bailey , J.L. Gross, D. Hennicken, N. Iqbal, T.A. Mansfield, J.F. List
63
THE DUAL PPARα/δ AGONIST GFT505 IMPROVES HEPATIC AND PERIPHERAL INSULIN SENSITIVITY IN ABDOMINALLY OBESE SUBJECTS
B. Cariou , R. Hanf, S. Lambert-Porcheron, Y. Zaïr, L. Flet, H. Vidal, B. Staels, M. Laville
64
EFFICACY AND SAFETY OF CANAGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES ON METFORMIN AND PIOGLITAZONE
T. Forst , R. Guthrie, R. Goldenberg, U. Vijapurkar, J. Yee, G. Meininger, P. Stein
65
THE SODIUM GLUCOSE COTRANSPORTER-2 (SGLT-2) INHIBITOR EMPAGLIFLOZIN LOWERS BLOOD PRESSURE INDEPENDENT OF WEIGHT OR HBA1C CHANGES
T. Hach , H.J.L. Heerspink, E. Pfarr, S. Lund, L. Ley, U.C. Broedl, H.J. Woerle
66
THE EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, SAFETY AND TOLERABILITY OF EMPAGLIFLOZIN, A POTENT SODIUM GLUCOSE COTRANSPORTER-2 INHIBITOR
S. Macha , P. Rose, M. Mattheus, R. Cinca, S. Pinnetti, U.C. Broedl, H.J. Woerle
67
LONG-TERM EFFICACY AND SAFETY OF DAPAGLIFLOZIN VS GLIPIZIDE ADDED TO METFORMIN IN INADEQUATELY CONTROLLED T2DM
M.A. Nauck , S. Del Prato, K. Rohwedder, A. Theuerkauf, A.M. Langkilde, S.J. Parikh
68
CANAGLIFLOZIN COMPARED TO GLIMEPIRIDE IN SUBJECTS WITH TYPE 2 DIABETES ON BACKGROUND METFORMIN
L. Niskanen
, W.T. Cefalu, L.A. Leiter, J. Xie, D. Balis, W. Canovatchel, G. Meininger
69
SAFETY OF DAPAGLIFLOZIN IN CLINICAL TRIALS FOR T2DM
A. Ptaszynska , S.J. Parikh, K.M. Johnsson, A.M. Apanovitch, J.E. Sugg, J.F. List
70
CANAGLIFLOZIN COMPARED TO SITAGLIPTIN IN SUBJECTS WITH TYPE 2 DIABETES ON METFORMIN AND SULFONYLUREA
G. Schernthaner
, J. Gross, M. Fu, J. Yee, M. Kawaguchi, W. Canovatchel, G. Meininger
71
CANAGLIFLOZIN IMPROVES GLYCEMIA IN TYPE 2 DIABETES SUBJECTS POORLY CONTROLLED WITH DIET AND EXERCISE
K. Stenlöf , W.T. Cefalu, C. Tong, S. Sha, J. Yee, M. Alba, W. Canovatchel, G. Meininger
72
CANAGLIFLOZIN REDUCES BODY WEIGHT MAINLY THROUGH LOSS OF FAT MASS IN SUBJECTS WITH TYPE 2 DIABETES
S. Toubro
, W.T. Cefalu, J. Xie, D. Sullivan, K. Usiskin, W. Canovatchel, G. Meininger
73
CANAGLIFLOZIN IMPROVES GLYCEMIA IN SUBJECTS WITH TYPE 2 DIABETES ON METFORMIN PLUS SULFONYLUREA
J. Wilding
, C. Mathieu, L. Deng, S. Black, F. Vercruysse, W. Canovatchel, G. Meininger
74
EFFECTS OF THE SGLT2 INHIBITOR DAPAGLIFLOZIN BEYOND GLUCOSE REDUCTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
V. Woo
, E. Hardy, A. Ptaszynska, S.J. Parikh
75
EFFICACY AND SAFETY OF CANAGLIFLOZIN IN SUBJECTS WITH TYPE 2 DIABETES WITH MODERATE RENAL IMPAIRMENT
V. Woo
, M. Davies, D. de Zeeuw, G. Bakris, K. Usiskin, C. Gassmann-Mayer, G. Meininger
76
LONG-TERM EFFECTIVENESS OF DAPAGLIFLOZIN OVER 104 WEEKS IN PATIENTS WITH T2DM INADEQUATELY CONTROLLED WITH INSULIN
V. Woo
, J. Wilding, K. Rohwedder, J.E. Sugg, S.J. Parikh
 
 
 
 
Board #
DIET/EXERCISE
77
EVOLUTION OF CARDIOVASCULAR LIFESTYLE BEHAVIOURS OCCURRING IN HYPERCHOLESTEROLEMIC PATIENTS CONCOMITANTLY TO THE INTAKE OF PHYTOSTEROL-SUPPLEMENTED YOGHURT
F.A. Allaert , J. Chapman, L. Masana, O. Descamps, E. Bosi, E. Bruckert
78
EFFECTS OF AN ENERGY-RESTRICTIVE DIET WITH OR WITHOUT EXERCISE ON THE METABOLIC SYNDROME IN PATIENTS WITH ABDOMINAL OBESITY
A. Berezina , O. Belyaeva, O. Berkovich, E. Baranova, E. Shlyakhto
79
THE ROLE OF HEALTH PRODUCTION AS A DETERMINANT OF METS IN A COHORT OF CHILEAN ADOLESCENTS
P. Correa Burrows, M. Reyes, D. Chavez-Yenter, E. Blanco, S. Gahagan, R.A. Burrows
80
METABOLIC SYNDROME AND INSULIN RESISTANCE IN ADULT PATIENTS UNDERGOING DIET-INDUCED WEIGHT LOSS PROGRAM
L.F. Grandisoli
, N.R.T. Damasceno, E.K.N. Aguchiku
81
THE EFFECT OF FREQUENCY OF MEALS ON BODY WEIGHT, HBA1C AND RESTING ENERGY EXPENDITURE IN PATIENTS WITH TYPE 2 DIABETES
H. Kahleova , L. Belinova, M. Hill, T. Pelikanova
82
DOES SHORT-TERM VERY LOW CALORIE DIET HAVE POSITIVE EFFECT ON ENDOTHELIAL ACTIVATION IN OBESE TYPE 2 DIABETIC PATIENTS?
J. Skrha Jr. , M. Prazny, J. Soupal, T. Stulc, L. Landova, J. Kvasnicka, M. Jarolimkova, J. Skrha, M. Kalousova
83
EFFECTS OF LIFESTYLE INTERVENTION IN PERSONS AT RISK FOR TYPE 2 DIABETES MELLITUS - RESULTS FROM A RANDOMISED, CONTROLLED TRIAL
V.N. Nilsen , P.B. Bakke, G.H. Rohde, F.G. Gallefoss
84
EFFECT OF HIGH-FAT DIET AND MYRIOCIN ON THE LEVEL OF SELECTED SPHINGOLIPIDS IN THE RAT LIVER
M. Żendzian-Piotrowska
, D.M. Piotrowska, K. Kurek, P. Wiesiołek, J. Górski
 
 
 
 
Board #
GENETICS
85
EVALUATION OF MATERNAL PLASMA TOTAL CELL FREE FETAL (cff) DNA IN PREECLAMPTIC PREGNANCIES
Y.S. El Kassar , A.Z. Azzam, F.M. Saleh, S.R. Ahmed, D.M. Hashad
86
ASSOCIATION OF VDR GENE APAI POLYMORPHISM WITH SERUM LIPOPROTEIN LEVEL IN REPRODUCTIVE AGE WOMEN
T.L. Karonova
, E.V. Tsvetkova, A. Kostareva, A. Klushina, O.D. Belyaeva, E.P. Micheea, A.V. Berezina, E.N. Grineva
87
EVALUATION OF THE LEPR AND ERS1 GENES METHYLATIONS IN PRE AND POST MENOPAUSAL WOMEN
J.C. dos Santos , H.L. Wang, M.C. Almeida, A.R. Garofalo, M.F. Sampaio, M.H. Hirata, A. Bertolami, M.C. Bertolami, P.H.O. Lima
88
EFFECT OF THE HAPTOGLOBIN 2/2 GENOTYPE ON ENDOTHELIAL DYSFUNCTION IN TYPE 1 DIABETES MELLITUS
G. Llauradó , C. Gutiérrez, A. Cano, P. Gil, O. Giménez-Palop, J. Vendrell, J.M. González-Clemente
89
DIABETIC NEPHROPATHY IN TYPE 2 DIABETES: MPO T-764C AND INOS SER608LEU GENOTYPE RELATED TO OXIDATIVE STRESS
J. Makuc
, D. Petrovič
90
SREBP1 TARGETED GENE EXPRESSION PROFILE IN NEONATAL MICE LIVER WAS CHANGED BY MATERNAL DIET DURING GESTATION: MICROARRAY AND BIO-ANALYTIC BASED RESEARCH
H. Yu
91
ASSOCIATION STUDY BETWEEN TAQ-SNPS AND HAPLOTYPES OF CELL DEATH-INDUCING DNA FRAGMENTATION FACTOR ALPHA-LIKE FACTOR A (CIDEA) GENE AND OBESITY IN CHINESE HAN POPULATION
L.L. Zhang , J. Wu, J. Zhang, Y. Dai, L. Bian, W. Wang
92
OSBP-RELATED PROTEINS (ORPS) IN HUMAN ADIPOSE DEPOTS AND CULTURED ADIPOCYTES: EVIDENCE FOR IMPACTS ON THE ADIPOCYTE PHENOTYPE
Y. Zhou
, M.R. Robciuc, M. Wabitsch, A. Juuti, M. Leivonen, C. Ehnholm, H. Yki-Järvinen, V.M. Olkkonen
 
 
 
 
Board #
GLUCOSE CONTROL
93
PRELIMINARY RESULTS OF GLUCOSE METABOLISM AFTER 14 WEEKS OF ELECTROMYOSTIMULATION IN RECENT SPINAL CORD INJURED MEN
A. Arija-Blázquez
, S. Ceruelo-Abajo, M.S. Diaz-Merino, J.A. Godino-Durán, F. Navarro-Valdivielso, J. Florensa-Vila
94
ASSOCIATION OF ≥3% WEIGHT LOSS AND SELF-REPORTED ADHERENCE WITH 6-MONTH GLYCEMIC CONTROL IN T2DM: THE DELTA STUDY
C.M. McAdam-Marx
, B.K. Bellows, G.D. Wygant, J. Mukherjee, S.K. Unni, X. Ye, J.N. Liberman, U. Iloeje, D. Brixner
95
OMEGA 6 INTAKE MODULATES GLICEMIC CONTROL: RANDOMIZED, CONTROLLED AND DOUBLE BIND STUDY
C.P. Pappiani
, N.R.T. Damasceno
 
 
 
 
Board #
HYPOGLYCAEMIA
96
HYPOGLYCAEMIA EVENT RATES IN TYPE 2 DIABETES PATIENTS TREATED WITH INSULIN GLARGINE PLUS METFORMIN & SULPHONYLUREA
R. Bergenstal
, L. Meneghini, A.H. Barnett, T. Reid, M.P. Dain, W. Landgraf, A. Vlajnic, L. Traylor, J.H. DeVries
97
GAPP2™ SURVEY: T2DM PATIENTS USING INSULIN ANALOGUE WHO DOSE IRREGULARLY REPORT MORE HYPOS
M. Brod
, M. Peyrot, A. Rana, A.H. Barnett
98
GAPP2™ SURVEY: GERMAN T2DM PATIENTS ARE CONCERNED ABOUT HYPOS AND DOSING IRREGULARITIES WITH INSULIN
M. Kaiser
, M. Brod, U. Steiner, M. Peyrot
99
GLYCAEMIC VARIABILITY AND HYPOGLYCAEMIC EPISODES WITH METFORMIN, GLARGINE, AND COMBINATION THERAPY IN T2DM USING CGM
C. Köhler , F. Schaper, F. Pistrosch, J. Steiner, R. Staudte, W. Landgraf, S. Bilz, C. Schoner, M. Hanefeld
100
SAFETY RESULTS FROM OCAPI: A EUROPEAN OBSERVATIONAL COHORT STUDY OF INSULIN GLULISINE-TREATED CHILDREN AGED 6 TO 12 YEARS WITH TYPE 1 DIABETES
M. Konstantinova , V. Loizeau, V. Pilorget, A. Cali, T. Danne
101
GAPP2™ SURVEY: HYPOS MORE COMMON IN US TYPE 2 DIABETES PATIENTS, BUT IMPORTANCE UNDER-RECOGNISED
L.F. Meneghini
, M. Brod, T.M. Hobbs, M. Peyrot
102
REDUCED NOCTURNAL HYPOGLYCAEMIA WITH INSULIN DEGLUDEC VS INSULIN GLARGINE: A 2-YEAR TRIAL IN TYPE 2 DIABETES
H.W. Rodbard , B. Zinman, A. Philis-Tsimikas, B. Cariou, Y. Handelsman, T. Vang Skjøth, A. Rana, C. Mathieu
 
 
 
 
Board #
INSULIN THERAPY
103
200 U/ML INSULIN DEGLUDEC HAS SIMILAR EFFICACY AND SAFETY TO 100 U/ML INSULIN GLARGINE IN PEOPLE WITH TYPE 2 DIABETES
R. Bergenstal
, A. Bhargava, R. Jain, A. Rana, H. Mersebach, S.C.L. Gough
104
CLINICAL CHARACTERISTICS OF TYPE 2 DIABETIC PATIENTS AT THE TIME OF INSULIN INITIATION IN TUNISIAN PATIENTS
K. Bouchrit
, N. Khelifi, I. Kammoun, Z. Turki, C. Ben Slama
105
EVALUATION OF A BASAL-PLUS REGIMEN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS OF DIFFERENT AGES: A POOLED ANALYSIS
A. Cali , M.P. Dain, S. Del Prato, M. Lankisch, J. Lin, D.R Owens, G. Dailey
106
EFFICACY AND SAFETY OF INSULIN GLARGINE AMONG TYPE 1 DIABETES PATIENTS IN THE US: ANALYSIS OF THE IMPACT DATABASE
P. Chase , E. Wang, A. Cali, M.P. Dain, J. Lin, S. Garg
107
EVALUATION OF A BASAL-BOLUS REGIMEN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS OF DIFFERENT AGES: A POOLED ANALYSIS
G. Dailey
, A. Cali, J. Lin, E. Wang
108
PLASMA INSULIN GLARGINE AND ITS METABOLITE M1 AND M2 AFTER SUBCUTANEOUS INJECTION OF THERAPEUTIC DOSES IN YOUNG CHILDREN WITH T1DM: RESULTS FROM THE PRESCHOOL STUDY
T. Danne
, P. Johnston, G. Xiang, A. Cali, M.P. Dain, A. Philotheou
109
HEALTH STATUS IN PEOPLE WITH TYPE 2 DIABETES IS SIGNIFICANTLY IMPROVED WITH INSULIN DEGLUDEC VS INSULIN GLARGINE
N. Freemantle
, L. Meneghini, T.E. Christensen, M.L. Wolden, J. Jendle
110
LONG ACTING INSULIN ANALOGS EXPOSURE AND CANCER MORTALITY
S. Ioacara , C. Guja, C. Ionescu-Tirgoviste, S. Fica, S. Martin, S. Sabau, C. Tiu
111
OPPORTUNITIES OF INSULIN PUMP THERAPY TO OVERCOME RESISTANCE TO EXOGENOUS-INJECTED INSULIN IN TYPE 2 DIABETES PATIENT- CLINICAL CASE
I.V. Kononenko
, Y.I. Philippov, O.M. Smirnova, A.Y. Mayorov
112
PREDICTING FACTORS FOR DAILY INSULIN REQUIREMENT AT THE ONSET OF TYPE 1 DIABETES
M. Maiza , H. Ben Abdessalem, E. Haouat, L. Ben Salem, C. Ben Slama
113
EARLY ONSET OF GLYCAEMIC IMPROVEMENTS AFTER INSULIN INITIATION WITH GLARGINE IN T2DM PATIENTS UNCONTROLLED WITH OADS
D. Owens , M.P. Dain, W. Landgraf
 
 
 
 
Board #
METABOLIC SYNDROME
114
ASSOCIATION OF BODY MASS INDEX, SAGITTAL ABDOMINAL DIAMETER AND WAIST-HIP RATIO WITH CARDIOMETABOLIC RISK FACTORS AND ADIPOCYTOKINES IN ARAB CHILDREN AND ADOLESCENTS O. Al-Attas
115
PREVALENCES OF OVERWEIGHT, OBESITY, HYPERGLYCAEMIA, HYPERTENSION AND DYSLIPIDAEMIA IN THE CO-OPERATION COUNCIL OF THE ARAB STATES OF THE GULF (GCC): SYSTEMATIC REVIEW
L.A. Alhyas
, A. MCKay, A. Majeed, A. Balasanthiran
116
HYPERURICEMY AS A COMPONENT METABOLIC SYNDROME IN MENOPAUSAL WOMEN
G.B. Dorofeeva
, I. Dorofeev
117
ANALYSIS OF RESULTS OVER TIME IN PREVENTIVE INTERVENTION FOR METABOLIC SYNDROME
H. Imai
, H. Nakao, F. Sata
118
ASSOCIATION BETWEEN THE NUMBER OF METABOLIC FACTORS AND LEFT VENTRICULAR MASS INDEX AS ASSESSED BY 64-MULTIDETECTOR COMPUTED TOMOGRAPHY
R. Mitsutake
, H. Urata, K. Okamura, S. Miura, K. Saku
119
METABOLIC SYNDROME IN THE HYPERTENSIVE: CAN LARGE EVENING MEAL BE THE CULPRIT?
M.S. Park
, H.J. Yoon
120
METABOLIC SYNDROME IN EMPLOYEES AT A PUBLIC UNIVERSITY: ASSOCIATED FACTORS AND CONCORDANCE BETWEEN DIAGNOSIS CRITERIA
A.M. Pimenta
, A.L.M. Leão
121
OBESITY AND METABOLIC SYNDROME AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA
M.B. Vilanova
, J. Montserrat-Capdevila, M. Falguera, N. Miró, M. Rodríguez, R. Llovet, M. Calderó, M. Falguera, G. Pascual, J. Sangrà, V. Sanchez, M. Pena
 
 
 
 
Board #
METAL/VITAMIN/FOOD CONSUMPTION
122
VITAMIN D SUPPLEMENTATION AS AN ADJUVANT THERAPY FOR PATIENTS WITH T2DM: AN 18-MONTH PROSPECTIVE INTERVENTIONAL STUDY
O. Al-Attas
123
TEA AND COFFEE CONSUMPTION IN RELATION TO VITAMIN D AND CALCIUM LEVELS IN SAUDI ADOLESCENTS
O. Al-Attas
124
GREEN TEA EXTRACTS AMELIORATE DIABETIC COMPLICATIONS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS
M. Ali
, M.M. Thomson, K.K. Al-Qattan, H.I. Nazar, D.J. JS
125
CASE CONTROL STUDY OF THE EFFECT OF A NUTRITIONAL STRATEGY CALLED «GOURMET NUTRITION» ON THE COMPLIANCE TO CARDIOVASCULAR LIFESTYLES RECOMMENDATIONS
F.A. Allaert
, F. Paillard, T. Coutureau
126
EFFECT OF GREEN TEA ON ADIPOSITY, METABOLIC PROFILE, BLOOD PRESSURE AND ENDOTHELIAL FUNCTION IN OBESE PRE-HYPERTENSIVE WOMEN
L. de Paula Nogueira
, D.T. Valença, M.G. Rodrigues, E.R. Soares, M.R.S.G. Torres, R.L. Carvalho, J.F. Noguiera Neto, A.F. Sanjuliani
127
IRON DEFICIT IN TYPE 2 NON DYALISED DIABETIC PATIENTS
S.S. Iancu
, C. Bondor, I.A. Veresiu, M.M. Coca
128
BODY WEIGHT AND SEX AFFECT APPETITE HORMONES IN RESPONSE TO MACRONUTRIENT INGESTION BY ADOLESCENTS
B.P. Patel , G.H. Anderson, S. Vien, N. Bellissimo, B. McCrindle, J. Hamilton
129
ASSOCIATION OF VITAMIN D3 LEVELS AND OBESITY IN TYPE 2 DIABETICS
Z.A. Velija-Asimi
 
 
 
 
Board #
OBESITY
130
ASSOCIATION BETWEEN HEALTH PRODUCTION PROFILES AND ABDOMINAL OBESITY IN CHILEAN CHILDREN AND ADOLESCENTS: A COMPARATIVE ANALYSIS
R.A. Burrows
, P. Correa Burrows
131
RELATIONSHIP BETWEEN BODY FAT RATIO AND MORTALITY
E. Goh
132
DOES PSYCHOLOGICAL INTERVENTION AFFECT WEIGHT LOSS IN OBESE PATIENTS ATTENDING A WEIGHT MANAGEMENT CLINIC?
N. Haboubi , C. Bracchi, J. Gray, S. Jones, A. Weaver, J. Reynolds, G. Goldings
133
PREVALENCE OF OBESITY AMONG ARAB WOMEN IN NAZARETH
M. Kandalaft Khoury , O. Mordechai, N. Shehadeh
134
OBESITY IN KUWAIT: AN EPIDEMIOLOGIC REVIEW
S. Karageorgi , O. Alsmadi
135
METFORMIN (MET) PREVENTS WEIGHT GAIN IN RESIDENTIAL PSYCHIATRIC YOUTH ON SECOND GENERATION ANTIPSYCHOTICS (SGA)
D.J. Klein
, D. Tsevat, P. Steiner, M. Sorter, L.M. Dolan
136
THE ROLE OF THE ENZYME 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 IN HUMAN OBESITY
L. Máčová
, H. Zamrazilová, M. Bičíková
137
THE EFFECT OF VISCERAL FAT AREA AND ADIPOCYTOKINES ON ACUTE MYOCARDIAL INFARCTION:
A CASE-CONTROL STUDY IN ADULT KOREAN POPULATION
J. Rho , K. Lee, Y. Suh, K. Yum
138
HIGH MULTIVITAMIN INTAKE DURING PREGNANCY MODIFIES BRAIN NEUROCIRCUITS REGULATING ENERGY HOMEOSTASIS RESULTING IN OBESE MALE WISTAR OFFSPRING
D. Sanchez-Hernandez , C.E. Cho, S. Reza-Lopez, A. Poon, R. Kubant, J. Wang, P. Huot, G.H. Anderson
139
ANTI-OBESITY EFFECT OF DEHYDROEPIANDROSTERONE: FEASIBLE INVOLVEMENT OF 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 INHIBITION IN RODENT ADIPOSE TISSUE
N. Tagawa , Y. Kobayashi
 
 
Board #
POSTER ADDENDUM
140
EFFECT OF HIGH FIBER DIET IN TYPE 2 DIABETIC PATIENTS ON METABOLIC AND CARDIOVASCULAR RISK MARKERS IN INDIAN PUNJABI POPULATION
R. Kapoor, R. Duggal, R. Sharma, R. Kapoor, S. Kapoor
141
SEX SPECIFIC ASSOCIATION AND PREVALENCE OF INSULIN RESISTANCE (HOMA-IR) IN INDIAN DIABETIC POPULATION
R. Kapoor, R. Duggal, R. Kapoor, S. Kapoor
142
ADIPOKINE SECRETION IN ADIPOSE TISSUE AND METABOLIC STATUS DURING LONG TERM DIETARY INTERVENTION IN OBESE WOMEN
M. Siklova, L. Rossmeiselova, L. Malisova, J. Kracmerova, V. Stich
143
DAPAGLIFLOZIN IMPROVES GLYCAEMIC CONTROL AND REDUCES BODY WEIGHT ACROSS THE T2DM TREATMENT CONTINUUM
S.J. Parikh, L. Wei, C. Wessman, E. Hardy, A. Ptaszynska
144
LONG-TERM SAFETY AND TOLERABILITY OF SAXAGLIPTIN ADD-ON THERAPY IN ELDERLY PATIENTS WITH TYPE 2 DIABETES
N. Iqbal, E. Allen, M. Donovan, K.P. Öhman
145
Saxagliptin Effectively Reduces HbA1c and Is Well Tolerated as Add-On to a Combination of Metformin and Sulfonylurea
R.G. Moses, S. Kalra, D. Brook, J. Sockler, J. Visvanathan, S.A. Fisher
146
EFFECT OF BERBERINE ADMINISTRATION ON METABOLIC SYNDROME, INSULIN SENSITIVITY AND INSULIN SECRETION
M. González-Ortiz, K.G. Pérez-Rubio, E. Martínez-Abundis, J.A. Robles-Cervantes, M.C. Espinel-Bermudez


Home    Sponsors    Regesteration    Contact Us   
 
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 16/01/2014 Created by     WebStudio.co.il